StonvexLoading…
StonvexStonvexStonvexCore line items from ICHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-26 | Annual 2024 2024-12-27 | Annual 2023 2023-12-29 | Annual 2022 2022-12-30 |
|---|---|---|---|---|
Revenue | $947.65M | $849.04M | $811.12M | $1.28B |
Operating Income | $-39.27M | $-7.64M | $-10.89M | $85.82M |
Net Income | $-52.78M | $-20.82M | $-42.98M | $72.80M |
EPS (Diluted) | $-1.54 | $-0.64 | $-1.47 | $2.51 |
Total Assets | $942.88M | $995.56M | $938.48M | $1.08B |
Total Liabilities | $278.99M | $297.23M | $373.80M | $496.25M |
Cash & Equivalents | $98.29M | $108.67M | $79.95M | $86.47M |
Free Cash Flow OCF − CapEx | $-6.28M | $10.24M | $42.14M | $2.02M |
Shares Outstanding | 34.43M | 33.86M | 29.44M | 28.86M |